NysnoBio

NysnoBio's at Pacifichem 2021! A fully-virtual Congress this year, don't miss Jennifer Johnston, PhD, Cofounder and CEO of NysnoBio, on Fri at 10:35 PST as she discusses small molecule activation of Parkin E3 ubiquitin ligase.
nysnobio.com

In a webinar brought to you by Bio-Techne and The Scientist, Dr. Jennifer Johnston discusses the past 20 years of her career, and how her basic research into ubiquitin-proteasome system elements—including Parkin E3 ligase—continues to provide the insight needed to move gene therapy and small molecule therapeutics toward the clinic. Watch it here!

Pioneering Research in E3 Ubiquitin Ligase Biology and Applications to Drug Discovery — NysnoBio In a webinar brought to you by Bio-Techne and The Scientist, Dr. Jennifer Johnston discusses the past 20 years of her career, and how her basic research into ubiquitin-proteasome system elements—including Parkin E3 ligase—continues to

Washington Post Health: Professor J. William Langston, NysnoBio Scientific Advisory Board (SAB) Member, discusses susceptibility to Parkinson's disease.

Parkinson’s strikes more men than women. Researchers have worked for decades to learn why. Some experts are calling for a long-term study that would follow generations of people to learn more about this progressive disorder of the nervous system.